Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTO1 | P78417 | 2/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.53 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | TTPA | P49638 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20635558 | 0.88 | AKT1 (0.57) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL20635618 | 0.88 | GSTO1 (0.73) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL20635624 | 0.86 | LMNA (0.56) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL20634802 | 0.86 | GSTO1 (0.54) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL705369 | 0.85 | GSTO1 (0.76) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL708027 | 0.83 | MEN1 (0.72) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL25118491 | 0.83 | MEN1 (0.72) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL20634805 | 0.81 | GSTO1 (0.51) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL20917306 | 0.81 | GSTO1 (0.73) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL25080534 | 0.78 | AKT1 (0.65) | GSTO1PTPN1MEN1KMT2APDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | GSTO1 148/4885PTPN1 1238/4885MEN1 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.